LEO Pharma

As a purpose-driven company, we recognize our responsibility to minimize negative environmental impacts and contribute to a more sustainable future. LEO Pharma is announcing its commitment to long-term company-wide emission reductions in line with science-based net-zero with the Science-Based Target initiative (SBTi) by 2050. This commitment will involve an extensive decarbonization plan across the company’s operations, aligning with the Paris Agreement. This will be subject to validation from the SBTi which will be made within 24 months of this commitment. #DermatologyBeyondTheSkin #NetZero #LEOPharma

The impact of skin conditions goes beyond the skin. This World Mental Health Day, LEO Pharma aims to shed light on the psychological burden that skin diseases have on people’s lives. Skin diseases are the fourth most common of all human diseases, affecting almost one-third of the world’s population, yet their burden is often underestimated. Besides physical impact, skin diseases can affect psychological well-being in many ways, including feelings of embarrassment, stigmatization, sleeping difficulty, anxiety, depression and an impaired quality of life. In fact, people living with skin diseases consistently report that the psychological aspects are a major component of their disease — more than the physical symptoms for many. LEO Pharma is committed to raising awareness about the burden of skin conditions and to advancing the standard of care for those who need us most in medical dermatology. #LEOPharma #DermatologyBeyondTheSkin #WorldMentalHealthDay

We were thrilled to attend the #EADVCongress and showcase our extensive data and expertise across several skin conditions. Our onsite team acquired valuable insights that will help further our mission of advancing the standard of care in medical dermatology. Thank you to all those who stopped by our booth - it was a pleasure meeting each and every one of you. #DermatologyBeyondTheSkin #LEOPharma

Our late-breaker presentation to support those living with #AtopicDermatitis has just come to an end at the European Academy of Dermatology and Venereology Congress. That makes 5 late-breaker presentations LEO Pharma has presented this week! In addition, 23 other scientific posters were presented for a range of skin conditions, truly reinforcing our dedication to addressing the needs of those living with skin conditions. #DermatologyBeyondTheSkin #LEOPharma

🎤Reporting live from the #EADVCongress Our late-breaker presentation to support those living with #AtopicDermatitis has just finished at the European Academy of Dermatology and Venereology Congress. Keep an eye out for more such exciting updates in the coming days… #DermatologyBeyondTheSkin

🎤Reporting live from the #EADVCongress One of our late-breaker presentations for #ChronicHandEczema has just concluded at this year’s European Academy of Dermatology and Venereology. We look forward to showcasing the rest of our scientific programme in the coming days. #DermatologyBeyondTheSkin

We are excited to be onsite at the #EADVCongress in Amsterdam and look forward to unveiling our most extensive scientific programme to date, including 5 late-breakers and 23 scientific posters to support those living with a range of #SkinConditions. Visit our booth at #B28 and meet our team on the ground. #DermatologyBeyondTheSkin #LEOPharma

We are EADV ready! This week, LEO Pharma is in Amsterdam for #EADVCongress 2024, where we will showcase a variety of new clinical and real-world data for a range of skin conditions. We are looking forward to collaborating on the latest advances in medical dermatology We will be at booth B28 – see you all soon! #DermatologyBeyondTheSkin #LEOPharma

It is World Patient Safety Day! Today, we join global efforts in recognizing the significance of patient safety as a top global health concern. This year's theme focuses on ‘improving diagnosis for patient safety’, emphasizing the importance of accurate and timely diagnosis in addressing health issues. As a global leader in dermatology, LEO Pharma continues to prioritize patient safety, working with unwavering dedication towards advancing the standard of care for those living with skin conditions. #LEOPharma #DermatologyBeyondTheSkin #WorldPatientSafetyDay

On this World Atopic Eczema Day, LEO Pharma shines a spotlight on atopic dermatitis (AD) - the most common form of eczema that affects millions of people across the globe. This chronic inflammatory skin condition not only causes physical discomfort with symptoms such as itch and pain, but also impacts the quality of life for patients, their families and caregivers. With AD often persisting into and sometimes beginning in adulthood, the condition results in a lifetime patient burden that is one of the largest among diseases worldwide. At LEO Pharma, we are driven to innovate to address such patient needs and strive to make a fundamental difference for those living with skin conditions. #LEOPharma #DermatologyBeyondTheSkin #WorldAtopicEczemaDay #AtopicDermatitis